Ibi-334 (Anti-B7-H3 & EGFR)
Product Specifications
Target
EGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Ibi-334 is an ADCC-enhanced bispecific antibody targeting B7-H3 and EGFR, showing potent preclinical efficacy in solid tumors. It blocks EGFR signaling while utilizing a finely tuned B7-H3 arm to enhance inhibition. M.W 145.58 kDa.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2056-100 1x 100 µL
CD7 (T-Cell Leukemia Marker) (CD7/3737), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 